Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial.
Br J Dermatol. 2023 Oct 25;189(5):531-539. doi: 10.1093/bjd/ljad240.
Br J Dermatol. 2023.
PMID: 37463508
Free article.
Clinical Trial.
A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man.
Saghari M, Gal P, Ziagkos D, Burggraaf J, Powell JF, Brennan N, Rissmann R, van Doorn MBA, Moerland M.
Saghari M, et al.
Br J Clin Pharmacol. 2021 Apr;87(4):1953-1962. doi: 10.1111/bcp.14588. Epub 2020 Oct 28.
Br J Clin Pharmacol. 2021.
PMID: 33025648
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite